Fencamfamine is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the drug tend to rapidly develop tolerance and escalate their dose. Fencamfamine is discontinued (DEA controlled substance). References: de Aguiar CR, de Aguiar MJ, DeLucia R, Silva MT. Effect of dopamine and serotonin receptor antagonists on fencamfamine-induced abolition of latent inhibition. Eur J Pharmacol. 2013 Jan 5;698(1-3):246-51. doi: 10.1016/j.ejphar.2012.10.015. Epub 2012 Nov 2. PubMed PMID: 23123352.

纯度：≥98%

CAS：2240-14-4